With Big Pharma castoffs in hand, Mereo files for $81M IPO; London's Verona sees stock surge on PhIIb COPD data
→ Mereo BioPharma, a London biotech developing a pipeline of assets it snagged from Big Pharma shelves, is heading to the Nasdaq with hopes of …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
